Don’t let learners perform procedures directly on patients, without having practiced them in an appropriate simulated model, and without proper tutorial supervision.
Teaching based on “see one, do one, teach one” is still widely adopted, despite that several studies have shown its limits in validity and most of all in patient safety, when compared with available metods of simulation. The ethical imperative is therefore “never for...
Don’t address topics about clinical or organization choices without considering their ethical, social and inter-professional aspects, patient’s expectations and values, and the most appropriate teaching setting (hospital, primary care).
Human relationship is essential in medical care: to exclude from the process of education the relationship between the different actors of the process of care and the natural context where it occurs, fails to prepare learners to cope with the challenges of...
Avoid the use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients suffering from hypertension, cardiac insufficiency or chronic kidney disease – whatever their cause (including diabetes).
Numerous drugs can cause renal insufficiency, or facilitate its progression, so they should be used with particular caution. The so-called NSAIDs (non-steroidal anti-inflammatory drugs) are the most often used painkillers (e.g. nimesulide, ketoprofen, diclofenac,...
Do not administer erythropoiesis stimulating agents (ESA) to patients with chronic kidney disease (CKD) and spontaneous hemoglobin levels between 10 and 11 g/dL with no symptoms of anemization. The same applies to patients who have not been tested for blood ferritin levels and transferrin saturation, at least.
The target of 10-11 gr/dL of hemoglobin has been identified in patients with chronic kidney disease (CKD) as the hemoglobin level associated with a lower risk of complications, particularly for the cardiovascular system. It is also pointless to administer ESA without...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments